Overall, our results indicate that human Val129-PrP polymorphic variant is a strong molecular protector against BSE zoonotic transmission but fails to prevent human-to-human vCJD transmission. This evidence concerns the gene PRNP and variant Creutzfeldt-Jakob disease.